- Home
- AVY vs PEN Comparison
AVY vs PEN Comparison
Compare AVY & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVY
- PEN
- Stock Information
- Founded
- AVY 1935
- PEN 2004
- Country
- AVY United States
- PEN United States
- Employees
- AVY N/A
- PEN N/A
- Industry
- AVY Containers/Packaging
- PEN Medical/Dental Instruments
- Sector
- AVY Consumer Discretionary
- PEN Health Care
- Exchange
- AVY Nasdaq
- PEN Nasdaq
- Market Cap
- AVY 13.1B
- PEN 10.6B
- IPO Year
- AVY N/A
- PEN 2015
- Fundamental
- Price
- AVY $165.66
- PEN $272.98
- Analyst Decision
- AVY Buy
- PEN Strong Buy
- Analyst Count
- AVY 10
- PEN 16
- Target Price
- AVY $197.00
- PEN $302.93
- AVG Volume (30 Days)
- AVY 546.7K
- PEN 457.5K
- Earning Date
- AVY 10-22-2025
- PEN 10-29-2025
- Dividend Yield
- AVY 2.27%
- PEN N/A
- EPS Growth
- AVY 14.63
- PEN 916.05
- EPS
- AVY 8.92
- PEN 3.74
- Revenue
- AVY $8,737,900,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- AVY $2.20
- PEN $15.52
- Revenue Next Year
- AVY $3.95
- PEN $14.20
- P/E Ratio
- AVY $18.57
- PEN $72.91
- Revenue Growth
- AVY 1.66
- PEN 12.92
- 52 Week Low
- AVY $157.00
- PEN $184.80
- 52 Week High
- AVY $224.38
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- AVY 39.51
- PEN 56.68
- Support Level
- AVY $164.30
- PEN $270.54
- Resistance Level
- AVY $168.86
- PEN $288.91
- Average True Range (ATR)
- AVY 2.83
- PEN 7.36
- MACD
- AVY -0.46
- PEN -0.15
- Stochastic Oscillator
- AVY 9.64
- PEN 41.57
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.